News
-
-
-
PRESS RELEASE
DBV Technologies Announces Inclusion in the Euronext Tech Leaders Index
DBV Technologies has been included in the Euronext Tech Leaders index, spotlighting high-growth European companies in technology and adjacent sectors. The recognition reflects the company's progress in developing innovative treatment options -
-
-
PRESS RELEASE
DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference
DBV Technologies to participate in 1-on-1 investor meetings at Goldman Sachs Annual Global Healthcare Conference. CEO unavailable for fireside chat. Company focused on developing food allergy treatments with VIASKIN patch technology -
-
-
PRESS RELEASE
DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026
DBV Technologies to present new positive data from VITESSE study and preview THRIVE study at EAACI Congress 2026. VIASKIN Peanut Patch efficacy in peanut-allergic children with atopic comorbidities -